Saito H - Search Results

1

Estrogen agonistic/antagonistic effects of miproxifene phosphate (TAT-59).

Shibata J, Toko T, Saito H, Lykkesfeldt AE, Fujioka A, Sato K, Hashimoto A, Wierzba K, Yamada Y. Shibata J, et al. Among authors: saito h. Cancer Chemother Pharmacol. 2000;45(2):133-41. doi: 10.1007/s002800050021. Cancer Chemother Pharmacol. 2000. PMID: 10663628

2

[Antitumor activity of miproxifene phosphate (TAT-59) against human mammary carcinoma].

Toko T, Saito H, Fujioka A, Nukatuka M, Sato K, Hashimoto A, Shibata J, Yamada Y. Toko T, et al. Among authors: saito h. Gan To Kagaku Ryoho. 1998 May;25(6):829-38. Gan To Kagaku Ryoho. 1998. PMID: 9617321 Japanese.

3

[Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--growth-inhibitory activity of combination against human tumor xenograft].

Saito H, Okabe H, Nakano K, Fujioka A, Toko T, Takeda S, Unemi N. Saito H, et al. Gan To Kagaku Ryoho. 1995 Nov;22(13):1919-25. Gan To Kagaku Ryoho. 1995. PMID: 7487121 Japanese.

4

Specific distribution of TOP-53 to the lung and lung-localized tumor is determined by its interaction with phospholipids.

Yoshida M, Kobunai T, Aoyagi K, Saito H, Utsugi T, Wierzba K, Yamada Y. Yoshida M, et al. Among authors: saito h. Clin Cancer Res. 2000 Nov;6(11):4396-401. Clin Cancer Res. 2000. PMID: 11106259

5

[Experimental study of the effect of combined treatment of UFT with CDDP on human solid tumor-xenografts in nude mice].

Yamada Y, Saito H, Oie S, Takechi T, Nakano K, Takeda S. Yamada Y, et al. Among authors: saito h. Gan To Kagaku Ryoho. 1990 Jul;17(7):1327-31. Gan To Kagaku Ryoho. 1990. PMID: 2114827 Japanese.

6

[Antitumor and anticachectic activity of UFT in BALB/c mice bearing colon 26 adenocarcinoma].

Nukatsuka M, Fujioka A, Saito H, Nakano K, Uchida J, Oh-ie S, Nomura N, Takeda S, Unemi N, Ishitani K, et al. Nukatsuka M, et al. Among authors: saito h. Gan To Kagaku Ryoho. 1994 Sep;21(12):2013-20. Gan To Kagaku Ryoho. 1994. PMID: 8085852 Japanese.

7

Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.

Shirasaka T, Nakano K, Takechi T, Satake H, Uchida J, Fujioka A, Saito H, Okabe H, Oyama K, Takeda S, Unemi N, Fukushima M. Shirasaka T, et al. Among authors: saito h. Cancer Res. 1996 Jun 1;56(11):2602-6. Cancer Res. 1996. PMID: 8653704

8

Prolongation of survival period and improvement of cancer cachexia by long-term administration of UFT.

Nukatsuka M, Fujioka A, Saito H, Uchida J, Nakano K, Takeda S, Unemi N. Nukatsuka M, et al. Among authors: saito h. Cancer Lett. 1996 Jul 12;104(2):197-203. doi: 10.1016/0304-3835(96)04247-4. Cancer Lett. 1996. PMID: 8665488

9

[Prolongation of survival and antitumor activity of antitumor drugs in murine cancer cachexia model].

Nukatsuka M, Fujioka A, Saito H, Uchida J, Takeda S, Unemi N. Nukatsuka M, et al. Among authors: saito h. Gan To Kagaku Ryoho. 1996 Jun;23(7):887-92. Gan To Kagaku Ryoho. 1996. PMID: 8678537 Japanese.

10

Antitumor activity of FTC-092, a masked 5-trifluoromethyl-2'-deoxyuridine derivative.

Takeda S, Yamashita J, Saito H, Uchida J, Satake H, Yamada Y, Unemi N, Wataya Y, Hayatsu H. Takeda S, et al. Among authors: saito h. Cancer Chemother Pharmacol. 1991;29(2):122-6. doi: 10.1007/BF00687321. Cancer Chemother Pharmacol. 1991. PMID: 1760854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,650 results

Search Page

Filters